What is he best known for?
The fields of study he is best known for:
His primary areas of study are Virology, Virus, Immunology, Epstein–Barr virus and Molecular biology.
His Virology research integrates issues from Cell culture, Gene, Transfection and Antibody.
His biological study spans a wide range of topics, including Disease and Pathogenesis.
His studies link Cytotoxic T cell with Immunology.
The study incorporates disciplines such as Lytic cycle, Lymphoproliferative disorders, Lymphoma and Gammaherpesvirinae in addition to Epstein–Barr virus.
His Molecular biology research incorporates elements of Recombinant virus, Recombinant DNA, Interleukin-21 receptor, Complementary DNA and In vivo.
His most cited work include:
- LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. (3006 citations)
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Epstein-Barr Virus Infection (1267 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Virus, Immunology, Varicella zoster virus and Molecular biology.
His Virology research is multidisciplinary, incorporating elements of Antibody and Gene.
The various areas that he examines in his Virus study include Open reading frame, Cell culture and Mutant.
Immunology is closely attributed to Disease in his study.
His study in Varicella zoster virus is interdisciplinary in nature, drawing from both Immediate early protein, Kinase and Chickenpox.
His Molecular biology research is multidisciplinary, relying on both RNA, Apoptosis, Transfection, Transactivation and Complementary DNA.
He most often published in these fields:
- Virology (56.48%)
- Virus (47.55%)
- Immunology (33.72%)
What were the highlights of his more recent work (between 2017-2021)?
- Virology (56.48%)
- Immunology (33.72%)
- Virus (47.55%)
In recent papers he was focusing on the following fields of study:
Jeffrey I. Cohen focuses on Virology, Immunology, Virus, Antibody and Immune system.
His Herpes simplex virus and Epstein–Barr virus infection study, which is part of a larger body of work in Virology, is frequently linked to Coronavirus and Severe acute respiratory syndrome coronavirus 2, bridging the gap between disciplines.
Jeffrey I. Cohen combines subjects such as Hemophagocytic lymphohistiocytosis, Disease and Case-control study with his study of Immunology.
Many of his studies involve connections with topics such as Cell biology and Virus.
The concepts of his T cell study are interwoven with issues in Protein kinase domain, Cancer research and Common variable immunodeficiency.
His research in the fields of BZLF1 overlaps with other disciplines such as Nasopharyngeal carcinoma.
Between 2017 and 2021, his most popular works were:
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
- Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. (117 citations)
- Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients (67 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Immunology, Virology, Virus, Antibody and Epstein–Barr virus.
His Immunology study combines topics in areas such as Disease and CD38.
His Virology research includes themes of Epitope and Immunity.
His Virus study incorporates themes from Hematopoietic stem cell transplantation and Lymphoproliferative disorders, Lymphoma.
His study in the field of Viral Vaccine also crosses realms of Coronavirus.
His Epstein–Barr virus research includes elements of Genome, Diffuse large B-cell lymphoma and B cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
